How well do health systems monitor HIV-associated comorbidities? HIV Outcomes at HIV Drug Therapy Glasgow 2018
News
25 October 2018

How well do health systems monitor HIV-associated comorbidities? HIV Outcomes at HIV Drug Therapy Glasgow 2018

Steering group co-chair Professor Jane Anderson (Consultant Physician, Homerton University Hospital, London) will present findings from HIV Outcomes' assessment of how effectively health systems are monitoring HIV-associated comorbidities at this year's HIV Drug Therapy conference in Glasgow on 28-31 October 2018.

While HIV has become a chronic condition, evidence suggests that there are a growing number of people living with HIV suffering from non-AIDS-defining comorbidities. Using current global and European frameworks, the HIV Outcomes abstract assesses whether existing monitoring frameworks sufficiently enable European countries to observe and understand the comorbidities that impact on the health and well-being of people living with HIV.

The abstract is taken from research work being undertaken by the HIV Outcomes study group.

More updates All

18 May 2022
[pdf-embedder url="http://hivoutcomes.eu/wp-content/uploads/2022/05/HIV_Outcomes_HRQoL_Mapping.pdf"]
More
15 April 2022
For the first time, the Secretariats running HIV Outcomes Europe, Italy, Spain, Romania and Germany met to explore potential opportunities for cooperation and learn how they are working to improve HRQoL for people living with HIV in their respective settings.
More
16 February 2022
While innovative therapies have helped turn HIV from a life-threatening disease into a long-lasting, chronic disease, people living with HIV are living longer but not necessarily living well. It is ...
More
Filters
This initiative is enabled by sponsorship provided by Gilead Sciences and ViiV Healthcare.